Japanese translation of Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trial
Version 2 2023-03-15, 12:49Version 2 2023-03-15, 12:49
Version 1 2023-02-24, 09:31Version 1 2023-02-24, 09:31
online resource
posted on 2023-03-15, 12:49authored byMatthew R. Smith, Maha Hussain, Fred Saad, Karim Fizazi, Cora N Sternberg, David Crawford, Jan Manarite, David Muslin, Thomas Farrington, Bertrand Tombal
Japanese translation of Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a patient and caregiver perspective and plain language summary of the ARASENS trial